Loading...
ROCO
4167
Market cap228mUSD
Oct 08, Last price  
22.00TWD
1D
7.58%
1Q
5.01%
Jan 2017
-15.45%
IPO
-21.23%
Name

Savior Lifetec Corp

Chart & performance

D1W1MN
ROCO:4167 chart
P/E
13.67
P/S
6.07
EPS
1.61
Div yield, %
1.86%
Shrs. gr., 5y
-1.62%
Rev. gr., 5y
-8.04%
Revenues
1.20b
-1.28%
786,335,000837,816,0001,000,632,0001,018,801,0001,120,609,0001,532,150,0001,618,119,0001,104,691,0001,318,694,0001,827,240,0001,743,785,0001,265,749,0001,050,277,0001,217,327,0001,201,690,000
Net income
534m
+192.60%
-234,562,000-452,834,000-228,703,000-355,790,000-493,793,000-207,697,00022,273,000-359,547,000-44,047,000250,941,000-4,763,00020,616,00030,030,000182,380,000533,640,000
CFO
-21m
L
-458,821,000-227,587,000-85,389,000-92,409,000-415,816,000-76,090,000260,886,000-189,842,000156,401,00091,251,000-168,338,000581,772,000387,952,000518,378,000-21,041,000
Dividend
Jul 28, 20260.8593 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan.

Key people

Rebecca Lee
Chairman of the Board · since 2018
Chih-Fang Chen
General Manager · since 2022
Ming-Hui Chen
Deputy General Manager · since 2023
I-Hsiu Chen
Deputy General Manager · since 2022
Chia-Chu Chou
Deputy General Manager, Director · since 2022
Yen-Lan Lin
Deputy General Manager · since 2023
Kuo-Wei Lin
Head of Finance & Accounting, Corporate Governance Officer · since 2024
Yung Fa-d Chen
Director · since 2022
Zheng Chen
Director · since 2018
Hsing-Yung Chung
Director · since 2020
Jung-Cheng Hsieh
Director · since 2023
Ryh-Yan Chang
Independent Director · since 2014
Chin-Hua Cheng
Independent Director · since 2022
Chih-Ming Lin
Independent Director · since 2020
URL
https://www.saviorlifetec.com.tw/en/
IPO date
Dec 21, 2012
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT